CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine

Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.

CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine

CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium

Moderna finalizes plan for long-term strategic partnership with Canada

Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually

Celogics license in NEXEL's Cardiosight-S for global distribution

The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development

ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine

Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".

IDT Biologika collaborates with Exothera to push forward the scale-up of viral vaccines

This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry

Canada approves plant-based Covid-19 vaccine

Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine

Prestige BioPharma’s Tuznue receives EU-GMP certification

Prestige BioPharma’s facility receives EU-GMP certification

The facility will manufacture its Herceptin biosimilar, Tuznue